GENPHARMASEC
|
The Current P/B Ratio of GENPHARMASEC is 0.78.
| Share Price | ₹0.9 | Mar 23,2026 |
| Market Cap | ₹50.9 Cr | |
| Book Value | ₹65.2 Cr | Mar2025 - Consolidated Results |
| Price/Book | 0.78x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of GENPHARMASEC
Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹50.9 Cr] as on Mar 23,2026
(/) Book Value [ ₹65.2 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 0.78x ]
P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.
Thus, for GENPHARMASEC , the investors are currently willing to pay '0.78 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of GENPHARMASEC !
The chart below summarizes the trend in P/B Ratio of GENPHARMASEC over the last five years.
Thus, for GENPHARMASEC , the investors are currently willing to pay '0.78 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of GENPHARMASEC !
The chart below summarizes the trend in P/B Ratio of GENPHARMASEC over the last five years.
Historical PB (Price/Book ) ratio chart of GENPHARMASEC
PB Ratio Performance Analysis for GENPHARMASEC
- GENPHARMASEC 's latest p/b ratio is 0.78x.
- GENPHARMASEC 's p/b ratio for fiscal years ending Mar2025 to Mar2023 averaged 3.05x.
- GENPHARMASEC 's operated at median p/b ratio of 1.92x from fiscal years ending March 2018 to 2022.
- Looking back at the last 3 fiscal years, GENPHARMASEC 's p/b ratio peaked in Mar2023 at 5.62x.
- GENPHARMASEC 's p/b ratio hit its five-year low in Mar2025 of 1.61x.
- GENPHARMASEC 's p/b ratio for fiscal years ending Mar2025 to Mar2023 averaged 3.05x.
- GENPHARMASEC 's operated at median p/b ratio of 1.92x from fiscal years ending March 2018 to 2022.
- Looking back at the last 3 fiscal years, GENPHARMASEC 's p/b ratio peaked in Mar2023 at 5.62x.
- GENPHARMASEC 's p/b ratio hit its five-year low in Mar2025 of 1.61x.
How does GENPHARMASEC 's P/B Ratio benchmark against top 10 peers in Dyes & Pigments Industry?
| Peer Comparison (Dyes & Pigments Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| GENPHARMASEC | 65.16 | 0.78 | 50.9 |
| SUDARSHAN CHEMICAL INDUSTRIES LTD | 3,412.59 | 1.75 | 5,973.7 |
| KIRI INDUSTRIES LTD | 3,067.30 | 0.70 | 2,152.1 |
| VIDHI SPECIALTY FOOD INGREDIENTS LTD | 301.09 | 4.44 | 1,336.0 |
| SHREE PUSHKAR CHEMICALS & FERTILISERS LTD | 538.88 | 1.65 | 890.9 |
| BODAL CHEMICALS LTD | 1,104.77 | 0.65 | 717.4 |
| BHAGERIA INDUSTRIES LTD | 558.24 | 1.06 | 589.2 |
| DYNEMIC PRODUCTS LTD | 224.28 | 1.29 | 288.9 |
| PODDAR PIGMENTS LTD | 363.41 | 0.61 | 222.2 |
| ASAHI SONGWON COLORS LTD | 255.04 | 0.92 | 234.7 |
| JAYSYNTH ORGOCHEM LTD | 122.94 | 1.17 | 143.7 |
Dyes & Pigments Industry Benchmark (Top 10) PB Analysis vs GENPHARMASEC 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 0.61x |
| Max industry PB | 4.44x |
| Median industry PB | 1.06x |
| Average industry PB | 1.37x |
You may also like the below Video Courses
